We are live on ! Find out more
AGL icon

Agilon Health

121 hedge funds and large institutions have $10.1B invested in Agilon Health in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 31

0.01% more ownership

Funds ownership: 3.98%3.99% (+0.01%)

4% less capital invested

Capital invested by funds: $10.6B → $10.1B (-$429M)

8% less call options, than puts

Call options by funds: $15.4M | Put options by funds: $16.7M

8% less funds holding

Funds holding: 132121 (-11)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

25% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 36

Holders
121
Holders Change
-11
Holders Change %
-8.33%
% of All Funds
1.91%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
27
Increased
44
Reduced
31
Closed
36
Calls
$15.4M
Puts
$16.7M
Net Calls
-$1.29M
Net Calls Change
-$1.85M
Name Holding Trade Value Shares
Change
Change in
Stake
CDR
1
Clayton Dubilier & Rice
New York
$5.22B
Morgan Stanley
2
Morgan Stanley
New York
$1.12B +$30.5M +59,185 +3%
Capital World Investors
3
Capital World Investors
California
$921M +$9.41M +18,258 +1%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$769M +$201M +390,118 +47%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$471M +$37.8M +73,395 +11%
Vanguard Group
6
Vanguard Group
Pennsylvania
$336M +$3.65M +7,090 +1%
Capital Research Global Investors
7
Capital Research Global Investors
California
$250M +$31.7M +61,460 +18%
RSCM
8
Rock Springs Capital Management
Maryland
$194M +$2.99M +5,800 +2%
BlackRock
9
BlackRock
New York
$159M -$34.8M -67,494 -21%
Brown Advisory
10
Brown Advisory
Maryland
$92M +$4.91M +9,523 +7%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$86.5M -$14.4M -27,956 -17%
DCP
12
Durable Capital Partners
Maryland
$75.8M -$32.3M -62,675 -34%
State Street
13
State Street
Massachusetts
$47.2M +$4.16M +8,073 +12%
Bank of America
14
Bank of America
North Carolina
$29.7M +$198K +384 +0.8%
Deutsche Bank
15
Deutsche Bank
Germany
$28.2M -$2M -3,872 -8%
NU
16
Northwestern University
Illinois
$28.2M
Geode Capital Management
17
Geode Capital Management
Massachusetts
$25.2M +$1.17M +2,262 +6%
Norges Bank
18
Norges Bank
Norway
$24.7M +$3.2M +6,208 +19%
Amundi
19
Amundi
France
$18.2M +$1.93M +3,748 +15%
Thrivent Financial for Lutherans
20
Thrivent Financial for Lutherans
Minnesota
$17.8M -$7.61M -14,772 -34%
IM
21
Islet Management
New York
$16.5M
Goldman Sachs
22
Goldman Sachs
New York
$13.3M -$1.67M -3,245 -13%
Public Employees Retirement Association of Colorado
23
Public Employees Retirement Association of Colorado
Colorado
$11.1M
N
24
Nuveen
North Carolina
$10.8M +$165K +321 +2%
Northern Trust
25
Northern Trust
Illinois
$10.4M +$370K +718 +5%

AGL Hedge Fund Activity: Q1 2022 in Review

121 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q1 2022, worth a combined $10.1B — down 4.1% from $10.6B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of AGL and 27 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 44 added.

The largest buyer was Fidelity Investments, adding an estimated $201M. The largest seller was BlackRock, cutting an estimated $34.8M.

  • 121 institutional investors held Agilon Health (AGL) as of Q1 2022, down from 132 in Q4 2021.
  • Funds reported $10.1B of Agilon Health stock for Q1 2022, down 4.1% quarter-over-quarter.
  • 27 funds opened new Agilon Health positions in Q1 2022 and 36 closed out, a net change of -9 holders.
  • The largest Agilon Health buyer in Q1 2022 was Fidelity Investments, an estimated $201M added.
  • The largest Agilon Health seller in Q1 2022 was BlackRock, an estimated $34.8M sold.

Based on aggregated 13F filings for Q1 2022.